Simulations Plus, Inc. (NASDAQ:SLP) Receives $49.40 Consensus Target Price from Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) have earned a consensus rating of "Buy" from the seven analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $49.40.

SLP has been the topic of several recent analyst reports. KeyCorp lifted their price target on Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th.

Simulations Plus Stock Performance

Shares of SLP stock traded down $0.75 during trading on Friday, hitting $23.97. The company had a trading volume of 153,640 shares, compared to its average volume of 166,980. The firm has a market capitalization of $481.61 million, a P/E ratio of 59.93 and a beta of 0.89. The stock's 50-day moving average price is $31.15 and its 200 day moving average price is $30.72. Simulations Plus has a one year low of $23.73 and a one year high of $51.22.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the transaction, the director now owns 3,402,584 shares in the company, valued at $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 19.40% of the stock is currently owned by company insiders.

Remove Ads

Hedge Funds Weigh In On Simulations Plus

Several institutional investors and hedge funds have recently added to or reduced their stakes in SLP. First Horizon Advisors Inc. grew its stake in shares of Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after buying an additional 427 shares during the period. Johnson Financial Group Inc. acquired a new position in Simulations Plus during the 4th quarter worth about $39,000. Quantbot Technologies LP bought a new stake in shares of Simulations Plus in the 3rd quarter valued at about $59,000. Finally, Tower Research Capital LLC TRC increased its stake in shares of Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after buying an additional 764 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.